Cancer treatment and gonadal function: Experimental and established strategies for fertility preservation in children and young adults

The Lancet Diabetes and Endocrinology

Volumn 3, Issue 7, 2015, Pages 556-567

  Anderson, Richard A ^a   Mitchell, Rod T ^a   Kelsey, Thomas W ^b   Spears, Norah ^c   Telfer, Evelyn E ^c   Wallace, W Hamish B ^d  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF ST ANDREWS   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; DACARBAZINE; LUTEINIZING HORMONE; MUELLERIAN INHIBITING FACTOR; PROCARBAZINE;

AGE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER THERAPY; CRYOPRESERVATION; FERTILITY; FERTILIZATION IN VITRO; GONAD DYSFUNCTION; GONAD FUNCTION; HEALTH STATUS; HODGKIN DISEASE; HUMAN; NEOPLASM; OOCYTE; OVARY FOLLICLE; OVARY INSUFFICIENCY; PRIORITY JOURNAL; PUBERTY; RADIATION DOSE; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; SPERM; ADOLESCENT; ADULT; CHILD; DRUG EFFECTS; FEMALE; FERTILITY PRESERVATION; GONAD; MALE; NEOPLASMS; RADIATION RESPONSE; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; FEMALE; FERTILITY; FERTILITY PRESERVATION; GONADS; HUMANS; MALE; NEOPLASMS; RISK FACTORS; YOUNG ADULT;

EID: 84934440608     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(15)00039-X     Document Type: Review

References (115)

1. Peate M, Meiser B, Hickey M, Friedlander M The fertility-related concerns, needs and preferences of younger women with breast cancer: a systematic review. Breast Cancer Res Treat 2009, 116:215-223.
2. Schover LR, Brey K, Lichtin A, Lipshultz LI, Jeha S Oncologists' attitudes and practices regarding banking sperm before cancer treatment. J Clin Oncol 2002, 20:1890-1897.
3. Anderson RA, Weddell A, Spoudeas HA, et al. Do doctors discuss fertility issues before they treat young patients with cancer?. Human Reprod 2008, 10:2246-2251.
4. Peate M, Meiser B, Friedlander M, et al. It's now or never: fertility-related knowledge, decision-making preferences, and treatment intentions in young women with breast cancer-an Australian fertility decision aid collaborative group study. J Clin Oncol 2011, 29:1670-1677.
5. Yeomanson DJ, Morgan S, Pacey AA Discussing fertility preservation at the time of cancer diagnosis: dissatisfaction of young females. Pediatr Blood Cancer 2013, 60:1996-2000.
6. Saito K, Suzuki K, Iwasaki A, Yumura Y, Kubota Y Sperm cryopreservation before cancer chemotherapy helps in the emotional battle against cancer. Cancer 2005, 104:521-524.
7. Ginsberg JP, Li Y, Carlson CA, et al. Testicular tissue cryopreservation in prepubertal male children: an analysis of parental decision-making. Pediatr Blood Cancer 2014, 61:1673-1678.
8. De Vos M, Smitz J, Woodruff TK Fertility preservation in women with cancer. Lancet 2014, 384:1302-1310.
9. Wallace WH, Critchley HO, Anderson RA Optimizing reproductive outcome in children and young people with cancer. J Clin Oncol 2012, 30:3-5.
10. Morgan S, Anderson RA, Gourley C, Wallace WH, Spears N How do chemotherapeutic agents damage the ovary?. Hum Reprod Update 2012, 18:525-535.
11. Anderson RA, Wallace WH Antimullerian hormone, the assessment of the ovarian reserve and the reproductive outcome of the young patient with cancer. Fertil Steril 2013, 99:1469-1475.
12. Socie G, Salooja N, Cohen A, et al. Nonmalignant late effects after allogeneic stem cell transplantation. Blood 2003, 101:3373-3385.
13. Rowley MJ, Leach DR, Warner GA, Heller CG Effect of graded doses of ionizing radiation on the human testis. Radiat Res 1974, 59:665-678.
14. van der Kaaij MA, van Echten-Arends J, Simons AH, Kluin-Nelemans HC Fertility preservation after chemotherapy for Hodgkin lymphoma. Hematol Oncol 2010, 28:168-179.
15. Wallace WH, Thomson AB, Saran F, Kelsey TW Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys 2005, 62:738-744.
16. Wallace WH, Kelsey TW Human ovarian reserve from conception to the menopause. PLoS One 2010, 5:e8772.
17. Sanders JE, Hawley J, Levy W, et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 1996, 87:3045-3052.
18. Signorello LB, Cohen SS, Bosetti C, et al. Female survivors of childhood cancer: preterm birth and low birth weight among their children. J Natl Cancer Inst 2006, 98:1453-1461.
19. Signorello LB, Mulvihill JJ, Green DM, et al. Stillbirth and neonatal death in relation to radiation exposure before conception: a retrospective cohort study. Lancet 2010, 376:624-630.
20. Appelman-Dijkstra NM, Kokshoorn NE, Dekkers OM, et al. Pituitary dysfunction in adult patients after cranial radiotherapy: systematic review and meta-analysis. J Clin Endocrinol Metab 2011, 96:2330-2340.
21. Bath LE, Anderson RA, Critchley HOD, Kelnar CJH, Wallace WHB Hypothalamic-pituitary-ovarian dysfunction after prepubertal chemotherapy and cranial irradiation for acute leukaemia. Hum Reprod 2001, 16:1838-1844.
22. Petrek JA, Naughton MJ, Case LD, et al. Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study. J Clin Oncol 2006, 24:1045-1051.
23. Letourneau JM, Ebbel EE, Katz PP, et al. Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer. Cancer 2012, 118:1933-1939.
24. Chemaitilly W, Mertens AC, Mitby P, et al. Acute ovarian failure in the childhood cancer survivor study. J Clin Endocrinol Metab 2006, 91:1723-1728.
25. Dewailly D, Andersen CY, Balen A, et al. The physiology and clinical utility of anti-Müllerian hormone in women. Hum Reprod Update 2014, 20:370-385.
26. Kelsey TW, Wright P, Nelson SM, Anderson RA, Wallace WH A validated model of serum anti-Müllerian hormone from conception to menopause. PLoS One 2011, 6:e22024.
27. Bath LE, Wallace WH, Shaw MP, Fitzpatrick C, Anderson RA Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Müllerian hormone, inhibin B and ovarian ultrasound. Hum Reprod 2003, 18:2368-2374.
28. Anderson RA, Themmen APN, Al Qahtani A, Groome NP, Cameron DA The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Hum Reprod 2006, 21:2583-2592.
29. Brougham MF, Crofton PM, Johnson EJ, Evans N, Anderson RA, Wallace WH Anti-Mullerian hormone is a marker of gonadotoxicity in pre- and postpubertal girls treated for cancer: a prospective study. J Clin Endocrinol Metab 2012, 97:2059-2067.
30. Decanter C, Morschhauser F, Pigny P, Lefebvre C, Gallo C, Dewailly D Anti-Müllerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results. Reprod Biomed Online 2010, 20:280-285.
31. Lie Fong S, Laven JS, Hakvoort-Cammel FG, et al. Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone. Hum Reprod 2009, 24:982-990.
32. Rosendahl M, Andersen CY, Ernst E, et al. Ovarian function after removal of an entire ovary for cryopreservation of pieces of cortex prior to gonadotoxic treatment: a follow-up study. Hum Reprod 2008, 23:2475-2483.
33. Dillon KE, Sammel MD, Prewitt M, et al. Pretreatment antimüllerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapy. Fertil Steril 2013, 99:477-483.
34. Anderson RA, Cameron DA Pretreatment serum anti-müllerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer. J Clin Endocrinol Metab 2011, 96:1336-1343.
35. Anderson RA, Rosendahl M, Kelsey TW, Cameron DA Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer. Eur J Cancer 2013, 49:3404-3411.
36. Ruddy KJ, O'Neill A, Miller KD, et al. Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103. Breast Cancer Res Treat 2014, 144:591-597.
37. Hamre H, Kiserud CE, Ruud E, Thorsby PM, Fossa SD Gonadal function and parenthood 20 years after treatment for childhood lymphoma: a cross-sectional study. Pediatr Blood Cancer 2012, 59:271-277.
38. Barton SE, Najita JS, Ginsburgh ES, et al. Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol 2013, 14:873-881.
39. Mitchell RT, Saunders PT, Sharpe RM, Kelnar CJ, Wallace WH Male fertility and strategies for fertility preservation following childhood cancer treatment. Endocr Dev 2009, 15:101-134.
40. Kelnar CJ, McKinnell C, Walker M, et al. Testicular changes during infantile 'quiescence' in the marmoset and their gonadotrophin dependence: a model for investigating susceptibility of the prepubertal human testis to cancer therapy?. Hum Reprod 2002, 17:1367-1378.
41. Rivkees SA, Crawford JD The relationship of gonadal activity and chemotherapy-induced gonadal damage. JAMA 1988, 259:2123-2125.
42. Jahnukainen K, Ehmcke J, Hou M, Schlatt S Testicular function and fertility preservation in male cancer patients. Best Pract Res Clin Endocrinol Metab 2011, 25:287-302.
43. de Rooij DG, van de Kant HJ, Dol R, et al. Long-term effects of irradiation before adulthood on reproductive function in the male rhesus monkey. Biol Reprod 2002, 66:486-494.
44. Jahnukainen K, Ehmcke J, Quader MA, et al. Testicular recovery after irradiation differs in prepubertal and pubertal non-human primates, and can be enhanced by autologous germ cell transplantation. Hum Reprod 2011, 26:1945-1954.
45. Sharpe RM, McKinnell C, Kivlin C, Fisher JS Proliferation and functional maturation of Sertoli cells, and their relevance to disorders of testis function in adulthood. Reproduction 2003, 125:769-784.
46. van Beek RD, Smit M, van den Heuvel-Eibrink MM, et al. Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood. Hum Reprod 2007, 22:3215-3222.
47. Green DM, Zhu L, Zhang N, et al. Lack of specificity of plasma concentrations of inhibin B and follicle-stimulating hormone for identification of azoospermic survivors of childhood cancer: a report from the St Jude lifetime cohort study. J Clin Oncol 2013, 31:1324-1328.
48. Coccia PF, Pappo AS, Altman J, et al. Adolescent and young adult oncology, version 2.2014. J Natl Compr Canc Netw 2014, 12:21-32.
49. Wallace WH, Thompson L, Anderson RA Long term follow-up of survivors of childhood cancer: summary of updated SIGN guidance. BMJ 2013, 346:f1190.
50. Ji CY, Ohsawa S Onset of the release of spermatozoa (spermarche) in Chinese male youth. Am J Hum Biol 2000, 12:577-587.
51. Nielsen CT, Skakkebaek NE, Richardson DW, et al. Onset of the release of spermatozoa (spermarche) in boys in relation to age, testicular growth, pubic hair, and height. J Clin Endocrinol Metab 1986, 62:532-535.
52. Schaefer F, Marr J, Seidel C, Tilgen W, Scharer K Assessment of gonadal maturation by evaluation of spermaturia. Arch Dis Child 1990, 65:1205-1207.
53. Wyns C, Curaba M, Petit S, et al. Management of fertility preservation in prepubertal patients: 5 years' experience at the Catholic University of Louvain. Hum Reprod 2011, 26:737-747.
54. Chung K, Irani J, Knee G, Efymow B, Blasco L, Patrizio P Sperm cryopreservation for male patients with cancer: an epidemiological analysis at the University of Pennsylvania. Eur J Obstet Gynecol Reprod Biol 2004, 113(suppl 1):S7-11.
55. Lawrenz B, Fehm T, von Wolff M, et al. Reduced pretreatment ovarian reserve in premenopausal female patients with Hodgkin lymphoma or non-Hodgkin-lymphoma-evaluation by using antimüllerian hormone and retrieved oocytes. Fertil Steril 2012, 98:141-144.
56. Friedler S, Koc O, Gidoni Y, Raziel A, Ron-El R Ovarian response to stimulation for fertility preservation in women with malignant disease: a systematic review and meta-analysis. Fertil Steril 2012, 97:125-133.
57. van Dorp W, van den Heuvel-Eibrink MM, de Vries AC, et al. Decreased serum anti-Müllerian hormone levels in girls with newly diagnosed cancer. Hum Reprod 2014, 29:337-342.
58. Kollin C, Ritzen EM Cryptorchidism: a clinical perspective. Pediatr Endocrinol Rev 2014, 11(suppl 2):240-250.
59. Tschudin S, Bitzer J Psychological aspects of fertility preservation in men and women affected by cancer and other life-threatening diseases. Hum Reprod Update 2009, 15:587-597.
60. Oosterhuis BE, Goodwin T, Kiernan M, Hudson MM, Dahl GV Concerns about infertility risks among pediatric oncology patients and their parents. Pediatr Blood Cancer 2008, 50:85-89.
61. Petrillo SK, Desmeules P, Truong TQ, Devine PJ Detection of DNA damage in oocytes of small ovarian follicles following phosphoramide mustard exposures of cultured rodent ovaries in vitro. Toxicol Appl Pharmacol 2011, 253:94-102.
62. Morgan S, Lopes F, Gourley C, Anderson RA, Spears N Cisplatin and doxorubicin induce distinct mechanisms of ovarian follicle loss; imatinib provides selective protection only against cisplatin. PLoS One 2013, 8:e70117.
63. Lopes F, Smith R, Anderson RA, Spears N Docetaxel induces moderate ovarian toxicity in mice, primarily affecting granulosa cells of early growing follicles. Mol Hum Reprod 2014, 20:948-959.
64. Kalich-Philosoph L, Roness H, Carmely A, et al. Cyclophosphamide triggers follicle activation and "burnout" AS101 prevents follicle loss and preserves fertility. Sci Transl Med 2013, 5:185ra62.
65. Meirow D, Dor J, Kaufman B, et al. Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury. Hum Reprod 2007, 22:1626-1633.
66. Howell SJ, Shalet SM Effect of cancer therapy on pituitary-testicular axis. Int J Androl 2002, 25:269-276.
67. Thomson AB, Campbell AJ, Irvine DS, Anderson RA, Kelnar CJH, Wallace WHB Semen quality and spermatozoal DNA integrity in survivors of childhood cancer. Lancet 2002, 360:361-367.
68. Winther JF, Boice JD, Frederiksen K, et al. Radiotherapy for childhood cancer and risk for congenital malformations in offspring: a population-based cohort study. Clin Genet 2009, 75:50-56.
69. Stahl O, Boyd HA, Giwercman A, et al. Risk of birth abnormalities in the offspring of men with a history of cancer: a cohort study using Danish and Swedish national registries. J Natl Cancer Inst 2011, 103:398-406.
70. Signorello LB, Mulvihill JJ, Green DM, et al. Congenital anomalies in the children of cancer survivors: a report from the childhood cancer survivor study. J Clin Oncol 2012, 30:239-245.
71. Winther JF, Olsen JH, Wu H, et al. Genetic disease in the children of Danish survivors of childhood and adolescent cancer. J Clin Oncol 2012, 30:27-33.
72. Crofton PM, Ahmed SF, Wade JC, et al. Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia. J Clin Endocrinol Metab 1998, 83:3121-3129.
73. Long term follow up of survivors of childhood cancer. A national clinical guideline 2013, Scottish Intercollegiate Guidelines Network, Health Improvement Scotland, Edinburgh.
74. Langrish JP, Mills NL, Bath LE, et al. Cardiovascular effects of physiological and standard sex steroid replacement regimens in premature ovarian failure. Hypertension 2009, 53:805-811.
75. Crofton PM, Evans N, Bath LE, et al. Physiological versus standard sex steroid replacement in young women with premature ovarian failure: effects on bone mass acquisition and turnover. Clin Endocrinol (Oxf) 2010, 73:707-714.
76. O'Donnell RL, Warner P, Lee RJ, et al. Physiological sex steroid replacement in premature ovarian failure: randomized crossover trial of effect on uterine volume, endometrial thickness and blood flow, compared with a standard regimen. Hum Reprod 2012, 27:1130-1138.
77. Shah S, Forghani N, Durham E, Neely EK A randomized trial of transdermal and oral estrogen therapy in adolescent girls with hypogonadism. Int J Pediatr Endocrinol 2014, 2014:12.
78. Partridge AH, Ruddy KJ, Gelber S, et al. Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer. Fertil Steril 2010, 94:638-644.
79. Kenney LB, Cohen LE, Shnorhavorian M, et al. Male reproductive health after childhood, adolescent, and young adult cancers: a report from the Children's Oncology Group. J Clin Oncol 2012, 30:3408-3416.
80. Romerius P, Stahl O, Moell C, et al. Hypogonadism risk in men treated for childhood cancer. J Clin Endocrinol Metab 2009, 94:4180-4186.
81. Han TS, Bouloux PM What is the optimal therapy for young males with hypogonadotropic hypogonadism?. Clin Endocrinol (Oxf) 2010, 72:731-737.
82. Dunkel L, Quinton R Transition in endocrinology: induction of puberty. Eur J Endocrinol 2014, 170:R229-R239.
83. Fertility: assessment and treatment for people with fertility problems National Institute for Health and Care Excellence, (accessed Feb 3, 2015). https://www.nice.org.uk/guidance/cg156.
84. Ishiguro H, Yasuda Y, Tomita Y, et al. Gonadal shielding to irradiation is effective in protecting testicular growth and function in long-term survivors of bone marrow transplantation during childhood or adolescence. Bone Marrow Transplant 2007, 39:483-490.
85. Fawcett SL, Gomez AC, Barter SJ, Ditchfield M, Set P More harm than good? The anatomy of misguided shielding of the ovaries. Br J Radiol 2012, 85:E442-E447.
86. van Casteren NJ, van Santbrink EJ, van Inzen W, Romijn JC, Dohle GR Use rate and assisted reproduction technologies outcome of cryopreserved semen from 629 cancer patients. Fertil Steril 2008, 90:2245-2250.
87. Schmidt KL, Larsen E, Bangsboll S, Meinertz H, Carlsen E, Andersen AN Assisted reproduction in male cancer survivors: fertility treatment and outcome in 67 couples. Hum Reprod 2004, 19:2806-2810.
88. Cakmak H, Katz A, Cedars MI, Rosen MP Effective method for emergency fertility preservation: random-start controlled ovarian stimulation. Fertil Steril 2013, 100:1673-1680.
89. Edgar DH, Gook DA A critical appraisal of cryopreservation (slow cooling versus vitrification) of human oocytes and embryos. Hum Reprod Update 2012, 18:536-554.
90. Mature oocyte cryopreservation: a guideline. Fertil Steril 2013, 99:37-43. Practice Committees of American Society for Reproductive Medicine, Society for Assisted Reproductive TechnologySociety for Assisted Reproductive Technology.
91. Loren AW, Mangu PB, Beck LN, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013, 31:2500-2510.
92. Garcia-Velasco JA, Domingo J, Cobo A, Martinez M, Carmona L, Pellicer A Five years' experience using oocyte vitrification to preserve fertility for medical and nonmedical indications. Fertil Steril 2013, 99:1994-1999.
93. Shetty G, Meistrich ML Hormonal approaches to preservation and restoration of male fertility after cancer treatment. J Natl Cancer Inst Monogr 2005, 34:36-39.
94. Carmely A, Meirow D, Peretz A, Albeck M, Bartoov B, Sredni B Protective effect of the immunomodulator AS101 against cyclophosphamide-induced testicular damage in mice. Hum Reprod 2009, 24:1322-1329.
95. Keros V, Hultenby K, Borgstrom B, Fridstrom M, Jahnukainen K, Hovatta O Methods of cryopreservation of testicular tissue with viable spermatogonia in pre-pubertal boys undergoing gonadotoxic cancer treatment. Hum Reprod 2007, 22:1384-1395.
96. Wyns C, Van Langendonckt A, Wese FX, Donnez J, Curaba M Long-term spermatogonial survival in cryopreserved and xenografted immature human testicular tissue. Hum Reprod 2008, 23:2402-2414.
97. Baert Y, Van Saen D, Haentjens P, In't Veld P, Tournaye H, Goossens E What is the best cryopreservation protocol for human testicular tissue banking?. Hum Reprod 2013, 28:1816-1826.
98. Hermann BP, Sukhwani M, Winkler F, et al. Spermatogonial stem cell transplantation into rhesus testes regenerates spermatogenesis producing functional sperm. Cell Stem Cell 2012, 11:715-726.
99. Honaramooz A, Snedaker A, Boiani M, Scholer H, Dobrinski I, Schlatt S Sperm from neonatal mammalian testes grafted in mice. Nature 2002, 418:778-781.
100. Rathi R, Zeng W, Megee S, Conley A, Meyers S, Dobrinski I Maturation of testicular tissue from infant monkeys after xenografting into mice. Endocrinology 2008, 149:5288-5296.
101. Radford J, Shalet S, Lieberman B Fertility after treatment for cancer. Questions remain over ways of preserving ovarian and testicular tissue. BMJ 1999, 319:935-936.
102. Sato T, Katagiri K, Gohbara A, et al. In vitro production of functional sperm in cultured neonatal mouse testes. Nature 2011, 471:504-507.
103. Tournaye H, Dohle GR, Barratt CL Fertility preservation in men with cancer. Lancet 2014, 384:1295-1301.
104. Valli H, Phillips BT, Shetty G, et al. Germline stem cells: toward the regeneration of spermatogenesis. Fertil Steril 2014, 101:3-13.
105. Reichman DE, Davis OK, Zaninovic N, Rosenwaks Z, Goldschlag DE Fertility preservation using controlled ovarian hyperstimulation and oocyte cryopreservation in a premenarcheal female with myelodysplastic syndrome. Fertil Steril 2012, 98:1225-1228.
106. Donnez J, Dolmans MM Fertility preservation in women. Nat Rev Endocrinol 2013, 9:735-749.
107. Stern CJ, Gook D, Hale LG, et al. First reported clinical pregnancy following heterotopic grafting of cryopreserved ovarian tissue in a woman after a bilateral oophorectomy. Hum Reprod 2013, 28:2996-2999.
108. Donnez J, Dolmans MM, Pellicer A, et al. Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. Fertil Steril 2013, 99:1503-1513.
109. Ovarian tissue cryopreservation: a committee opinion. Fertil Steril 2014, 101:1237-1243. Practice Committee of American Society for Reproductive Medicine.
110. Rosendahl M, Greve T, Andersen CY The safety of transplanting cryopreserved ovarian tissue in cancer patients: a review of the literature. J Assist Reprod Genet 2013, 30:11-24.
111. Dolmans MM, Luyckx V, Donnez J, Andersen CY, Greve T Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue. Fertil Steril 2013, 99:1514-1522.
112. Wallace WH, Smith AG, Kelsey TW, Edgar AE, Anderson RA Fertility preservation for girls and young women with cancer: population-based validation of criteria for ovarian tissue cryopreservation. Lancet Oncol 2014, 15:1129-1136.
113. Poirot C, Abirached F, Prades M, Coussieu C, Bernaudin F, Piver P Induction of puberty by autograft of cryopreserved ovarian tissue. Lancet 2012, 379:588.
114. Ernst E, Kjaersgaard M, Birkebaek NH, Clausen N, Andersen CY Case report: stimulation of puberty in a girl with chemo- and radiation therapy induced ovarian failure by transplantation of a small part of her frozen/thawed ovarian tissue. Eur J Cancer 2013, 49:911-914.
115. Anderson RA, Hindmarsh PC, Wallace WH Induction of puberty by autograft of cryopreserved ovarian tissue in a patient previously treated for Ewing sarcoma. Eur J Cancer 2013, 49:2960-2961.